HOMB Should I Buy

Buy (long-term). HOMB is pulling back to a key support zone (~$28) while its higher-timeframe trend still looks constructive (bullish moving-average stack). Fundamentals from 2025 Q4 show solid YoY growth (revenue +6.9%, net income +17.6%, EPS +17.7%), and Wall Street remains positive with an Overweight rating and a $35 target. The main near-term negatives are weakening momentum (MACD turning down) and heavy insider selling, but for a beginner long-term investor who wants to deploy capital now (not wait), the current dip near support is an acceptable entry for a multi-year hold.

Price/levels: Last close $28.02, sitting right on major support (S1 $28.084; next support S2 $27.636). Resistance levels to watch: Pivot $28.81, then $29.54 and $29.98. Trend: Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), which supports a longer-term uptrend/healthy structure. Momentum: MACD histogram is negative (-0.0363) and expanding lower, signaling short-term downside momentum/softness. RSI(6) at ~41 is neutral-to-slightly weak (not oversold). Read-through: This looks like a pullback within a broader uptrend. A clean hold above ~$27.64–$28.08 would keep the bullish structure intact; a reclaim of ~$28.81 would improve the short-term setup.